← Eichor
Study identifier: NCT07295236 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Condition: Esophagojejunal Anastomotic Leak  ·  Sponsor: Ukrainian Society of Clinical Oncology

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.

This description comes directly from the study's public registry record.

Talk to the study team

Oleksii Dobrzhanskyi, MD  ·  +380638760185  ·  alekseydobrzhanskiy@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Cancer InstituteKyiv, UkraineRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07295236